ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,906Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 890

$1.09M Total Retail Price of All Prescriptions

Rank: 37 out of 890

411 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 411 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

25% of this provider’s 411 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 11,850 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 608 451 1 2
HYDROCODONE-ACETAMINOPHEN 480 305 S3 2 3
FUROSEMIDE 451 392 3 7
OMEPRAZOLE 272 208 4 8
CARVEDILOL 270 250 5 22
CITALOPRAM HBR 260 224 6 20
AMLODIPINE BESYLATE 260 219 6 1
SIMVASTATIN 260 206 6 5
METOPROLOL TARTRATE 247 203 9 15
LISINOPRIL 240 173 10 4
ADVAIR DISKUS 239 164 11 52
METFORMIN HCL 238 188 12 6
MELOXICAM 226 166 13 18
NAMENDA 214 196 14 36
GABAPENTIN 210 139 15 12
NEXIUM 210 135 15 14
ZOLPIDEM TARTRATE 198 96 17 19
TRAMADOL HCL 187 117 18 16
SERTRALINE HCL 183 114 19 26
WARFARIN SODIUM 171 133 20 24
LACTULOSE 160 141 21 112
ISOSORBIDE MONONITRATE ER 152 137 22 60
ALBUTEROL SULFATE 151 112 23 162
CLOPIDOGREL 150 135 24 28
QUETIAPINE FUMARATE 146 92 25 73
POTASSIUM CHLORIDE 144 123 26 11
TAMSULOSIN HCL 140 85 27 32
LANTUS 140 97 27 50
RANITIDINE HCL 132 90 29 49
DIOVAN 124 98 30 33
EXELON 122 106 31 113
PLAVIX 122 117 31 42
CARAFATE 119 95 33 261
CYMBALTA 118 71 34 45
BENAZEPRIL HCL 116 71 35 44
ROPINIROLE HCL 113 97 36 93
MEGESTROL ACETATE 112 105 R 37 92
GLIMEPIRIDE 112 70 37 27
DONEPEZIL HCL 108 99 39 30
KLOR-CON M20 107 63 40 72
PREDNISONE 104 79 41 47
FLUTICASONE PROPIONATE 101 53 42 39
ETODOLAC 100 76 43 197
METOPROLOL SUCCINATE 98 68 44 17
SINGULAIR 97 68 45 79
AMLODIPINE BESYLATE-BENAZEPRIL 96 78 46 41
OLANZAPINE 89 81 47 145
ESCITALOPRAM OXALATE 88 61 48 51
CIPROFLOXACIN HCL 87 78 49 58
CYCLOBENZAPRINE HCL 83 25 R 50 64
DIOVAN HCT 83 38 50 48
LYRICA 80 67 52 71
NOVOLIN R 80 75 52 153
ACTOS 79 51 54 88
ATORVASTATIN CALCIUM 77 73 55 13
ABILIFY 77 54 55 172
TRAZODONE HCL 76 61 57 40
CLONIDINE HCL 75 38 58 35
MIRTAZAPINE 75 56 58 82
DIGOXIN 75 68 58 65
RISPERIDONE 72 32 61 78
NASONEX 72 32 61 170
PRAVASTATIN SODIUM 71 59 63 10
SPIRIVA 71 54 63 66
DOXYCYCLINE HYCLATE 69 55 65 89
PROAIR HFA 68 32 66 55
ALENDRONATE SODIUM 68 62 66 38
JANUVIA 67 44 68 59
AMOX TR-POTASSIUM CLAVULANATE 67 60 68 132
FENTANYL 64 60 S2 70 151
IBUPROFEN 63 36 71 101
HYDROCHLOROTHIAZIDE 63 37 71 9
NITROFURANTOIN MONO-MACRO 62 55 73 181
PHENYTOIN SODIUM EXTENDED 62 48 73 111
COMBIVENT 61 38 75 144
CARBIDOPA-LEVODOPA 60 53 76 136
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 43 77 76
PROMETHAZINE HCL 58 20 R 78 104
RIVASTIGMINE 58 52 78 314
FAMOTIDINE 58 39 78 90
ZETIA 57 39 81 81
MONTELUKAST SODIUM 56 43 82 130
LEVOFLOXACIN 55 39 83 107
AZELASTINE HCL 53 33 84 293
OXYBUTYNIN CHLORIDE 52 52 85 139
AMITRIPTYLINE HCL 51 19 R 86 43
NYSTATIN 50 47 87 173
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.